- Home
- HSCS vs GLMD Comparison
HSCS vs GLMD Comparison
Compare HSCS & GLMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HSCS
- GLMD
- Stock Information
- Founded
- HSCS 2007
- GLMD 2000
- Country
- HSCS United States
- GLMD Israel
- Employees
- HSCS N/A
- GLMD N/A
- Industry
- HSCS Medical Specialities
- GLMD Biotechnology: Pharmaceutical Preparations
- Sector
- HSCS Health Care
- GLMD Health Care
- Exchange
- HSCS Nasdaq
- GLMD Nasdaq
- Market Cap
- HSCS 3.7M
- GLMD 4.1M
- IPO Year
- HSCS 2022
- GLMD 2014
- Fundamental
- Price
- HSCS $3.38
- GLMD $1.44
- Analyst Decision
- HSCS Strong Buy
- GLMD Hold
- Analyst Count
- HSCS 2
- GLMD 1
- Target Price
- HSCS $13.00
- GLMD N/A
- AVG Volume (30 Days)
- HSCS 139.1K
- GLMD 229.4K
- Earning Date
- HSCS 09-11-2025
- GLMD 08-27-2025
- Dividend Yield
- HSCS N/A
- GLMD N/A
- EPS Growth
- HSCS N/A
- GLMD N/A
- EPS
- HSCS N/A
- GLMD N/A
- Revenue
- HSCS $4,350.00
- GLMD N/A
- Revenue This Year
- HSCS $21,003.45
- GLMD N/A
- Revenue Next Year
- HSCS $533.33
- GLMD N/A
- P/E Ratio
- HSCS N/A
- GLMD N/A
- Revenue Growth
- HSCS N/A
- GLMD N/A
- 52 Week Low
- HSCS $2.36
- GLMD $1.15
- 52 Week High
- HSCS $6.47
- GLMD $23.80
- Technical
- Relative Strength Index (RSI)
- HSCS 44.73
- GLMD 39.22
- Support Level
- HSCS $3.33
- GLMD $1.38
- Resistance Level
- HSCS $3.82
- GLMD $1.52
- Average True Range (ATR)
- HSCS 0.32
- GLMD 0.11
- MACD
- HSCS 0.00
- GLMD -0.02
- Stochastic Oscillator
- HSCS 52.69
- GLMD 19.41
About HSCS Heart Test Laboratories Inc.
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.
About GLMD Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development of Aramchol. exclusively on developing Aramchol for the treatment of liver disease and were previously developing Aramchol for primary sclerosing cholangitis, PSC, and exploring the feasibility of developing Aramchol for other fibro-inflammatory indications outside of NASH and fibrosis. The company is currently seeking to advance the development of Aramchol for oncological indications outside of NASH and fibrosis.